Kerman University of Medical Sciences

Document Type: Original Article


1 Assistant Professor, Pathology and Stem Cell Research Center AND Department of Pathology, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran

2 Researcher, Pathology and Stem Cell Research Center AND Department of Pathology, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran


Background: Opioids are amongst the most common abused drugs. Pathologic studies on opioid abuse are limited since the evaluation of inflammation and regeneration in brain tissue is not as simple as other tissues of the body. Thus, the present study aimed to determine the relationship between the dependence on morphine and inflammatory and regenerative processes. Methods: In this experimental study, 48 male wistar rats were divided into 6 groups. The dependent groups (3 groups) received 0.4 mg/ml morphine in drinking water for 7, 28, and 56 days. The control groups (3 groups) received sucrose solution in drinking water for the same period. The histopathological studies of the brain sample were done. The slides were stained by hematoxylin and eosin (H&E) and immunohistochemistry (IHC) staining method. The areas of brain were evaluated in terms of lymphocytic infiltration and glial scar. Findings: A significant difference was observed in the mean number of cells in the glial scar of the dependent group 3 (dependent for 56 days) among the control group (P = 0.040). Further, a significant relationship was reported between the increased duration of morphine use and the number of created scar glial cells. Furthermore, a significant increase in the number of astrocytes was observed in the affected areas. Conclusion: After long-term use, opioids can result in increased number of astrocytes and creating glial scar centers in the affected areas in response to the inflammation.


1. Bao G, Kang L, Li H, Li Y, Pu L, Xia P, et al. Morphine and heroin differentially modulate in vivo hippocampal LTP in opiate-dependent rat. Neuropsychopharmacology 2007; 32(8): 1738-49.
2. World drug report (2008); Trends in organized crime 2009; 12(3-4): 325-51.
3. Borne J, Riascos R, Cuellar H, Vargas D, Rojas R. Neuroimaging in drug and substance abuse part II: Opioids and solvents. Top Magn Reson Imaging 2005; 16(3): 239-45.
4. Boronat MA, Garcia-Fuster MJ, Garcia-Sevilla JA. Chronic morphine induces up-regulation of the pro-apoptotic Fas receptor and down-regulation of the anti-apoptotic Bcl-2 oncoprotein in rat brain. Br J Pharmacol 2001; 134(6): 1263-70.
5. Sklair-Tavron L, Shi WX, Lane SB, Harris HW, Bunney BS, Nestler EJ. Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proc Natl Acad Sci U S A 1996; 93(20): 11202-7.
6. Pezawas LM, Fischer G, Diamant K, Schneider C, Schindler SD, Thurnher M, et al. Cerebral CT findings in male opioid-dependent patients: Stereological, planimetric and linear measurements. Psychiatry Res 1998; 83(3): 139-47.
7. Bierczynska-Krzysik A, Bonar E, Drabik A, Noga M, Suder P, Dylag T, et al. Rat brain proteome in morphine dependence. Neurochem Int 2006; 49(4): 401-6.
8. Martin M, Hurley RA, Taber KH. Is opiate addiction associated with longstanding neurobiological changes? J Neuropsychiatry Clin Neuroscience 2007; 19(3): 242-8.
9. Kivisaari R, Kahkonen S, Puuskari V, Jokela O, Rapeli P, Autti T. Magnetic resonance imaging of severe, long-term, opiate-abuse patients without neurologic symptoms may show enlarged cerebrospinal spaces but no signs of brain pathology of vascular origin. Arch Med Res 2004; 35(5): 395-400.
10. Gendelman HE. Neural immunity: Friend or foe? J Neurovirol 2002; 8(6): 474-9.
11. 't Hart BA, den Dunnen WF. Commentary on special issue: CNS diseases and the immune system. J Neuroimmune Pharmacol 2013; 8(4): 757-9.
12. Ellison D, Cardao Chimelli LM, Harding B, Lowe LS. Neuropathology: A reference text of CNS pathology. 3rd ed. Philadelphia, PA: Mosby; 2013.
13. Rosai J. Rosai and Ackerman's surgical pathology e-book. Philadelphia, PA: Elsevier Health Sciences; 2011.
14. Kumar V, Abbas AK, Aster JC. Robbins basic pathology e-book. Philadelphia, PA: Elsevier Health Sciences; 2012.
15. Hu R, Zhou J, Luo C, Lin J, Wang X, Li X, et al. Glial scar and neuroregeneration: Histological, functional, and magnetic resonance imaging analysis in chronic spinal cord injury. J Neurosurg Spine 2010; 13(2): 169-80.
16. Rolls A, Shechter R, Schwartz M. The bright side of the glial scar in CNS repair. Nat Rev Neurosci 2009; 10(3): 235-41.
17. Huang L, Wu ZB, Zhuge Q, Zheng W, Shao B, Wang B, et al. Glial scar formation occurs in the human brain after ischemic stroke. Int J Med Sci 2014; 11(4): 344-8.
18. Hamzaee Moghaddam A, Yasemi MT, Seyfaddini RA. Case-control study to detect relationship between opium addiction, cigarette smoking and Alzheimer disease [Thesis]. Kerman, Iran: Kerman University of Medical Sciences; 1998. [In Persian].
19.Malekpour Afshar R, Seyfaddini R, Koohpayehzadeh Esfahani E, Nakhaee N, Eslammanesh T. Opium Dependency and Histopathologic Changes of Brain in Rat. J Rafsanjan Univ Med Sci 2010; 9(4): 273-80. [In Persian].
20. Lyoo IK, Pollack MH, Silveri MM, Ahn KH, Diaz CI, Hwang J, et al. Prefrontal and temporal gray matter density decreases in opiate dependence. Psychopharmacology (Berl) 2006; 184(2): 139-44.
21. Hammelrath L, Skokic S, Khmelinskii A, Hess A, van der Knaap N, Staring M, et al. Morphological maturation of the mouse brain: An in vivo MRI and histology investigation. Neuroimage 2016; 125: 144-52.